Skip to main content

Advertisement

Log in

Adjuvant therapies in critical care: steroids to treat infectious diseases

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Confalonieri M, Urbino R, Potena A et al (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248

    Article  PubMed  Google Scholar 

  2. Garcia-Vidal C, Calbo E, Pascual V et al (2007) Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J 30:951–956

    Article  PubMed  CAS  Google Scholar 

  3. Nie W, Zhang Y, Cheng J, Xiu Q (2012) Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One 7:e47926

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Torres A, Sibila O, Ferrer M et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677–686

    Article  PubMed  CAS  Google Scholar 

  5. Tagami T, Matsui H, Horiguchi H et al (2015) Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Eur Respir J 45:463–472

    Article  PubMed  CAS  Google Scholar 

  6. Siemieniuk RA, Meade MO, Alonso-Coello P et al (2015) Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med 163:519–528

    Article  PubMed  Google Scholar 

  7. Marti C, Grosgurin O, Harbarth S et al (2015) Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis. PLoS One 10:e0144032

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Horita N, Otsuka T, Haranaga S et al (2015) Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Sci Rep 5:14061

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Chen LP, Chen JH, Chen Y et al (2015) Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. World J Emerg Med 6:172–178

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wan YD, Sun TW, Liu ZQ et al (2016) Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest 149:209–219

    Article  PubMed  Google Scholar 

  11. Briel M, Spoorenberg SMC, Snijders D et al (2017) Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data meta-analysis. Clin Infect Dis. https://doi.org/10.1093/cid/cix801

    Article  Google Scholar 

  12. Pastores SM, Annane D, Rochwerg B, The Corticosteroid Guideline Task Force of SCCM and ESICM (2017) Guidelines for the diagnosis of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. https://doi.org/10.1007/s00134-017-4951-5

    Article  PubMed  Google Scholar 

  13. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS (2016) Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858

    Article  PubMed  Google Scholar 

  14. Cooley L, Dendle C, Wolf J et al (2014) Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies. Intern Med J 44(12b):1350–1363

    Article  PubMed  CAS  Google Scholar 

  15. Lemiale V, Debrumetz A, Delannoy et al (2013) Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia. Respir Res 14:87

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Hoffman SL, Punjabi NH, Kumala S et al (1984) Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 310(2):82–88

    Article  PubMed  CAS  Google Scholar 

  17. Rogerson SJ, Spooner VJ, Smith TA, Richens J (1991) Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 85:113–116

    Article  PubMed  CAS  Google Scholar 

  18. Brouwer MC, McIntyre P, Prasad K, van de Beek D (2015) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd004405.pub5

    Article  PubMed  Google Scholar 

  19. van de Beek D, Cabellos C, Dzupova O et al (2016) ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 22(Suppl 3):S37–S62

    Article  PubMed  Google Scholar 

  20. de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347(20):1549–1556

    Article  PubMed  Google Scholar 

  21. Prasad K, Singh MB, Ryan H (2016) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd002244.pub4

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wiysonge CS, Ntsekhe M, Thabane L et al (2017) Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd000526.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ryan H, Yoo J, Darsini P (2017) Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd001876.pub3

    Article  PubMed Central  PubMed  Google Scholar 

  24. Sharma SK, Mohan A, Sharma A, Mitra DK (2005) Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 5(7):415–430

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Manuel Pereira.

Ethics declarations

Conflicts of interest

José Manuel Pereira: received honoraria for lectures from MSD, Astellas, Pfizer and Novartis. Thiago Lisboa: no conflicts of interest. José Artur Paiva: no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pereira, J.M., Lisboa, T. & Paiva, JA. Adjuvant therapies in critical care: steroids to treat infectious diseases. Intensive Care Med 44, 1306–1309 (2018). https://doi.org/10.1007/s00134-017-5020-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-017-5020-9

Keywords

Navigation